HRSA Pushes to Dismiss Health Systems’ Lawsuits Over J&J 340B Audits Amid Uncertainty Under New Trump Admin

HRSA is seeking to dismiss five health systems' lawsuits in the U.S. District Court for the District of Columbia.
The Health Resources and Services Administration (HRSA) has continued to push a federal judge to dismiss five health systems’ lawsuits [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

STD Clinic Sues HRSA Over 340B Sites Terminations, Claims Agency Actions Will Force Clinic to Close

Sagebrush Health filed a federal lawsuit against HRSA after the agency terminated the 340B eligibility of several Sagebrush sites for allegedly violating program requirements.
Sagebrush Health, a Nevada-based STD clinic enrolled in the 340B program, has sued the Health Resources and Services Administration (HRSA), [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California Hospital Sues HRSA Over 340B Removal, Seeks Retroactive Eligibility

A California-based hospital sued HRSA in the U.S. District Court for the District of Columbia, alleging the agency "unlawfully" prevented the hospital from accessing the 340B program for six months.
A California-based hospital has sued the Health Resources and Services Administration (HRSA), alleging the agency unlawfully prevented it from accessing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

NYT Investigation Highlights Federal Law’s Unintended Harm to 340B Providers

A recent New York Times investigation found that part of a COVID-19 relief bill meant to lower drug prices actually increased costs for 340B providers and some of their most vulnerable patients.
A provision in a 2021 COVID-19 relief bill that sought to lower prescription drug prices has actually made some medications [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Just Before Departing, Biden Admin Announces Next 15 Drugs for Medicare Negotiations Amid IRA Uncertainty and 340B Questions

The second group of high-cost prescription drugs chosen for Medicare price negotiations were announced last week just ahead of former President Joe Biden's departure from the White House.
The Department of Health and Human Services (HHS) announced the second group of high-cost prescription drugs chosen for Medicare price [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Novartis is Fifth Drugmaker to Sue HRSA to Implement Controversial 340B Rebate Model

Novartis is suing HRSA to impose a controversial 340B rebate model that the agency has not authorized.
Novartis this week became the fifth manufacturer to sue the Health Resources and Services Administration (HRSA) to implement a 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

NYT Investigative Article Sparks Both Scrutiny and Support for 340B Prime Vendor Apexus

The New York Times published a Jan. 15 investigative article about the 340B prime vendor.
Yesterday’s New York Times investigative article alleging that the 340B prime vendor, Apexus, profited by driving 340B program expansion has [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Terminates 20 ‘Ineligible’ 340B Sites from STD Clinic; Clinic Rejects Allegations and Vows to Fight Back

HRSA has terminated 20 Sagebrush Health sites from the 340B program for allegedly violating program eligibility requirements.
The Health Resources and Services Administration (HRSA) has terminated the 340B status of 20 sites affiliated with the Nevada-based STD [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Heron, Dr. Reddy’s, Organon, CooperSurgical Issue NDC Changes 

Four drugmakers have notified 340B covered entities of changes to certain national drug codes (NDC) for their products over the past three weeks.
Four drugmakers have notified 340B covered entities of changes to certain national drug codes (NDC) for their products over the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmaker Lawsuit Targets 340B Eligibility of In-Kind STD Clinics; STD Grantee Denies Allegations

Three drugmakers sued HRSA in federal court over 340B eligibility for certain STD clinics, including Sagebrush Health.
Three large drugmakers are suing the federal government for allegedly allowing certain STD clinics to unlawfully participate in the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live